logo

Biocon Q2 Results: Company Swings Into Profit, Revenue Rises

The company has also announced that it has approved the issue of commercial papers of up to Rs 550 crore on a private placement basis.

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *